Idexx Laboratories IDXX CAG — Total Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's cag — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Idexx Laboratories's CAG — total revenue?
- Idexx Laboratories (IDXX) reported CAG — total revenue of $1.05B in Q1 2026.
- How has Idexx Laboratories's CAG — total revenue changed year-over-year?
- Idexx Laboratories's CAG — total revenue increased by 14.6% year-over-year, from $919.84M to $1.05B.
- What is the long-term trend for Idexx Laboratories's CAG — total revenue?
- Over 4 years (2021 to 2025), Idexx Laboratories's CAG — total revenue has grown at a 8.1% compound annual growth rate (CAGR), from $2.89B to $3.95B.
- What does CAG — total revenue mean?
- This metric represents the total gross sales generated by the Companion Animal Group segment, which includes diagnostic equipment, test kits, and software services for veterinary practices. It serves as the primary indicator of market demand and adoption for the company's core animal health diagnostic solutions. Growth in this segment reflects the company's ability to capture market share within the pet healthcare ecosystem.